Overview Phase 1 Study of Levocetirizine Status: Completed Trial end date: 2008-04-30 Target enrollment: Participant gender: Summary This is a single center, single blind, single dose, randomized, partial cross-over study to confirm bioequivalence between levocetirizine and cetirizine. Phase: Phase 1 Details Lead Sponsor: GlaxoSmithKlineTreatments: CetirizineLevocetirizine